Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance
Rene Niehus, Esther van Kleef, Yin Mo, Agata Turlej-Rogacka, Christine Lammens, Yehuda Carmeli, Herman Goossens, Evelina Tacconelli, Biljana Carevic, Liliana Preotescu, Surbhi Malhotra-Kumar, Ben S Cooper, Rene Niehus, Esther van Kleef, Yin Mo, Agata Turlej-Rogacka, Christine Lammens, Yehuda Carmeli, Herman Goossens, Evelina Tacconelli, Biljana Carevic, Liliana Preotescu, Surbhi Malhotra-Kumar, Ben S Cooper
Abstract
Antibiotic-induced perturbation of the human gut flora is expected to play an important role in mediating the relationship between antibiotic use and the population prevalence of antibiotic resistance in bacteria, but little is known about how antibiotics affect within-host resistance dynamics. Here we develop a data-driven model of the within-host dynamics of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae. We use blaCTX-M (the most widespread ESBL gene family) and 16S rRNA (a proxy for bacterial load) abundance data from 833 rectal swabs from 133 ESBL-positive patients followed up in a prospective cohort study in three European hospitals. We find that cefuroxime and ceftriaxone are associated with increased blaCTX-M abundance during treatment (21% and 10% daily increase, respectively), while treatment with meropenem, piperacillin-tazobactam, and oral ciprofloxacin is associated with decreased blaCTX-M (8% daily decrease for all). The model predicts that typical antibiotic exposures can have substantial long-term effects on blaCTX-M carriage duration.
Trial registration: ClinicalTrials.gov NCT01208519.
Keywords: antibiotic resistance; epidemiology; extended-spectrum beta-lactamase; global health; gut microbiota; human; infectious disease; microbiology; resistance carriage; state-space model; within-host dynamics.
Conflict of interest statement
RN, Ev, YM, AT, CL, YC, HG, ET, BC, LP, SM No competing interests declared, BC Reviewing Editor, eLife
© 2020, Niehus et al.
Figures
References
- Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MCJ, van Genderen PJJ, Goorhuis A, Grobusch MP, Lashof AMO, Molhoek N, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. The Lancet Infectious Diseases. 2017;17:78–85. doi: 10.1016/S1473-3099(16)30319-X.
- Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson DI, Brynildsen MP, Bumann D, Camilli A, Collins JJ, Dehio C, Fortune S, Ghigo JM, Hardt WD, Harms A, Heinemann M, Hung DT, Jenal U, Levin BR, Michiels J, Storz G, Tan MW, Tenson T, Van Melderen L, Zinkernagel A. Definitions and guidelines for research on antibiotic persistence. Nature Reviews Microbiology. 2019;17:441–448. doi: 10.1038/s41579-019-0196-3.
- Blanquart F. Evolutionary epidemiology models to predict the dynamics of antibiotic resistance. Evolutionary Applications. 2019;12:365–383. doi: 10.1111/eva.12753.
- Bonnet R. Growing group of Extended-Spectrum -Lactamases: the CTX-M Enzymes. Antimicrobial Agents and Chemotherapy. 2004;48:1–14. doi: 10.1128/AAC.48.1.1-14.2004.
- Buelow E, Gonzalez TB, Versluis D, Oostdijk EA, Ogilvie LA, van Mourik MS, Oosterink E, van Passel MW, Smidt H, D'Andrea MM, de Been M, Jones BV, Willems RJ, Bonten MJ, van Schaik W. Effects of selective digestive decontamination (SDD) on the gut resistome. Journal of Antimicrobial Chemotherapy. 2014;69:2215–2223. doi: 10.1093/jac/dku092.
- Buelow E, Bello González TDJ, Fuentes S, de Steenhuijsen Piters WAA, Lahti L, Bayjanov JR, Majoor EAM, Braat JC, van Mourik MSM, Oostdijk EAN, Willems RJL, Bonten MJM, van Passel MWJ, Smidt H, van Schaik W. Comparative gut Microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome. 2017;5:88. doi: 10.1186/s40168-017-0309-z.
- Carpenter B, Gelman A, Hoffman MD, Lee D, Goodrich B, Betancourt M, Brubaker M, Guo J, Li P, Riddell A. Stan : a probabilistic programming language. Journal of Statistical Software. 2017;76:1. doi: 10.18637/jss.v076.i01.
- CDC/NHSN . Surveillance Definitions for Specific Types of Infections. CDC; 2018.
- Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 2008;13:19044.
- Davies NG, Flasche S, Jit M, Atkins KE. Within-host dynamics shape antibiotic resistance in commensal bacteria. Nature Ecology & Evolution. 2019;3:440–449. doi: 10.1038/s41559-018-0786-x.
- Donnenberg MS. Enterobacteriaceae. In: Bennett M. D, editor. Principles and Practice of Infectious Diseases. Elsevier; 1979. pp. 2503–2517.
- Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clinical Infectious Diseases. 2004;39:219–226. doi: 10.1086/422002.
- Dubinsky-Pertzov B, Temkin E, Harbarth S, Fankhauser-Rodriguez C, Carevic B, Radovanovic I, Ris F, Kariv Y, Buchs NC, Schiffer E, Cohen Percia S, Nutman A, Fallach N, Klausner J, Carmeli Y, R-GNOSIS WP4 Study Group Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study. Clinical Infectious Diseases. 2019;68:1699–1704. doi: 10.1093/cid/ciy768.
- Faust K, Raes J. Microbial interactions: from networks to models. Nature Reviews Microbiology. 2012;10:538–550. doi: 10.1038/nrmicro2832.
- Garot D, Respaud R, Lanotte P, Simon N, Mercier E, Ehrmann S, Perrotin D, Dequin PF, Le Guellec C. Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal. British Journal of Clinical Pharmacology. 2011;72:758–767. doi: 10.1111/j.1365-2125.2011.04005.x.
- Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Statistical Science. 1992;7:457–472. doi: 10.1214/ss/1177011136.
- Gibson MK, Wang B, Ahmadi S, Burnham CA, Tarr PI, Warner BB, Dantas G. Developmental dynamics of the preterm infant gut Microbiota and antibiotic resistome. Nature Microbiology. 2016;1:16024. doi: 10.1038/nmicrobiol.2016.24.
- Jumbe N, Louie A, Leary R, Liu W, Deziel MR, Tam VH, Bachhawat R, Freeman C, Kahn JB, Bush K, Dudley MN, Miller MH, Drusano GL. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. Journal of Clinical Investigation. 2003;112:275–285. doi: 10.1172/JCI200316814.
- Knight GM, Costelloe C, Deeny SR, Moore LSP, Hopkins S, Johnson AP, Robotham JV, Holmes AH. Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study. BMC Medicine. 2018;16:137. doi: 10.1186/s12916-018-1121-8.
- Koopmans LH, Owen DB, Rosenblatt JI. Confidence intervals for the coefficient of variation for the normal and log normal distributions. Biometrika. 1964;51:25–32. doi: 10.1093/biomet/51.1-2.25.
- Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2001;33:1288–1294. doi: 10.1086/322667.
- Lemons DS, Langevin P. An Introduction to Stochastic Processes in Physics. JHU Press; 2002.
- Lerner A, Romano J, Chmelnitsky I, Navon-Venezia S, Edgar R, Carmeli Y. Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 2013;57:1474–1479. doi: 10.1128/AAC.01275-12.
- Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. PNAS. 2000;97:1938–1943. doi: 10.1073/pnas.97.4.1938.
- Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerging Infectious Diseases. 2002;8:347–354. doi: 10.3201/eid0804.010312.
- Livermore DM, Brown DF. Detection of beta-lactamase-mediated resistance. Journal of Antimicrobial Chemotherapy. 2001;48 Suppl 1:59–64. doi: 10.1093/jac/48.suppl_1.59.
- MacLean RC, Hall AR, Perron GG, Buckling A. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nature Reviews Genetics. 2010;11:405–414. doi: 10.1038/nrg2778.
- Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut Bacteria. Nature. 2018;555:623–628. doi: 10.1038/nature25979.
- Masci JR. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. An Official Publication of the Infectious Diseases Society of America; 2005. Clinical Infectious Diseases .
- Masterton R, Drusano G, Paterson DL, Park G. Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. Journal of Hospital Infection. 2003;55 Suppl 1:1–12. doi: 10.1016/S0195-6701(03)00294-9.
- Meletiadis J, Turlej-Rogacka A, Lerner A, Adler A, Tacconelli E, Mouton JW. Amplification of antimicrobial resistance in gut flora of patients treated with ceftriaxone. Antimicrobial Agents and Chemotherapy. 2017;61:e00473-17. doi: 10.1128/AAC.00473-17.
- Nahata MC, Barson WJ. Ceftriaxone: a third-generation cephalosporin. Drug Intelligence & Clinical Pharmacy. 1985;19:900–906. doi: 10.1177/106002808501901203.
- Neu HC, Fu KP. Cefuroxime, a Beta-Lactamase-Resistant cephalosporin with a broad spectrum of Gram-Positive and -Negative activity. Antimicrobial Agents and Chemotherapy. 1978;13:657–664. doi: 10.1128/AAC.13.4.657.
- Nguyen TT, Guedj J, Chachaty E, de Gunzburg J, Andremont A, Mentré F. Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted. PLOS Computational Biology. 2014;10:e1003840. doi: 10.1371/journal.pcbi.1003840.
- Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) Clinical Microbiology and Infection. 2000;6:460–463. doi: 10.1046/j.1469-0691.2000.00107.x.
- Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2001;33:126–128. doi: 10.1086/320882.
- Paterson DL. Resistance in gram-negative Bacteria: enterobacteriaceae. The American Journal of Medicine. 2006;119:S20–S28. doi: 10.1016/j.amjmed.2006.03.013.
- R Development Core Team . Vienna, Austria: R Foundation for Statistical Computing; 2016.
- Relman DA, Lipsitch M. Microbiome as a tool and a target in the effort to address antimicrobial resistance. PNAS. 2018;115:12902–12910. doi: 10.1073/pnas.1717163115.
- Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous Bacteria in faecal samples by real-time PCR. Journal of Applied Microbiology. 2004;97:1166–1177. doi: 10.1111/j.1365-2672.2004.02409.x.
- Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among Extended-Spectrum- -Lactamase-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 2005;49:2137–2139. doi: 10.1128/AAC.49.5.2137-2139.2005.
- Sorlózano A, Gutiérrez J, Romero JM, de Dios Luna J, Damas M, Piédrola G. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli. Journal of Basic Microbiology. 2007;47:413–416. doi: 10.1002/jobm.200710318.
- Stein RR, Bucci V, Toussaint NC, Buffie CG, Rätsch G, Pamer EG, Sander C, Xavier JB. Ecological modeling from time-series inference: insight into dynamics and stability of intestinal Microbiota. PLOS Computational Biology. 2013;9:e1003388. doi: 10.1371/journal.pcbi.1003388.
- Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant Bacteria and tuberculosis. The Lancet Infectious Diseases. 2018;18:318–327. doi: 10.1016/S1473-3099(17)30753-3.
- Tacconelli E, Górska A, De Angelis G, Lammens C, Restuccia G, Schrenzel J, Huson DH, Carević B, Preoţescu L, Carmeli Y, Kazma M, Spanu T, Carrara E, Malhotra-Kumar S, Gladstone BP. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative Bacteria using machine learning methods: a multicentre, prospective cohort study. Clinical Microbiology and Infection. 2020;26:87–94. doi: 10.1016/j.cmi.2019.05.013.
- Tedijanto C, Olesen SW, Grad YH, Lipsitch M. Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora. PNAS. 2018;115:E11988–E11995. doi: 10.1073/pnas.1810840115.
- Udekwu KI, Parrish N, Ankomah P, Baquero F, Levin BR. Functional relationship between bacterial cell density and the efficacy of antibiotics. Journal of Antimicrobial Chemotherapy. 2009;63:745–757. doi: 10.1093/jac/dkn554.
- Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. Journal of Clinical Microbiology. 2004;42:4769–4775. doi: 10.1128/JCM.42.10.4769-4775.2004.
- Vehtari A, Gelman A, Gabry J. Practical bayesian model evaluation using leave-one-out cross-validation and WAIC. Statistics and Computing. 2017;27:1413–1432. doi: 10.1007/s11222-016-9696-4.
- Vehtari A, Gelman A, Simpson D, Carpenter B, Bürkner PC. Rank-normalization, folding, and localization: an improved R̂ for assessing convergence of MCMC. arXiv. 2019
- Watanabe S. Asymptotic equivalence of Bayes cross validation and widely applicable information criterion in singular learning theory. Journal of Machine Learning Research. 2010;11:3571–3594.
- Webb GF, D'Agata EM, Magal P, Ruan S. A model of antibiotic-resistant bacterial epidemics in hospitals. PNAS. 2005;102:13343–13348. doi: 10.1073/pnas.0504053102.
- Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and Characterization of isolates from Europe, the Americas, and the western pacific region. Clinical Infectious Diseases. 2001;32 Suppl 2:S94–S103. doi: 10.1086/320182.
- Woerther PL, Micol JB, Angebault C, Pasquier F, Pilorge S, Bourhis JH, de Botton S, Gachot B, Chachaty E. Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of Bacteraemia isolates in patients with haematological malignancies. Journal of Medical Microbiology. 2015;64:676–681. doi: 10.1099/jmm.0.000078.
- Zhang L, Huang Y, Zhou Y, Buckley T, Wang HH. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut Microbiota. Antimicrobial Agents and Chemotherapy. 2013;57:3659–3666. doi: 10.1128/AAC.00670-13.
Source: PubMed